Laboratory Corporation of America® Holdings Announces 2016 Third Quarter Results and Updates 2016 Guidance

Q3 Net revenue of $2.4 billion , up 5% over last year Q3 Diluted EPS of $1.71 , up 14% over last year Q3 Adjusted EPS of $2.25 , up 9% over last year 2016 Adjusted EPS guidance updated to $8.70 - $8.90 , up 10% to 13% over 2015 Adjusted EPS BURLINGTON, N.C. --(BUSINESS WIRE)--Oct.

Covance Central Laboratory Services Ranks No. 1 in Global Investigator Satisfaction for the Third Consecutive Time

New study also shows that investigators are more willing to work with a sponsor when the sponsor chooses their preferred central lab BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 25, 2016-- An independent report has established that physician clinical-trial investigators identify Covance Central

German Court Issues Preliminary Injunction Against amedes Fetalis® Test for Infringement of Non-Invasive Prenatal Screening Patent

Date(s): 24-Oct-2016 4:05 PM For a complete listing of our news releases, please click here SAN DIEGO & BURLINGTON, N.C.--(BUSINESS WIRE)--Oct. 24, 2016-- Illumina, Inc. (NASDAQ: ILMN) and Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH), the world's leading healthcare

UPDATE: Press Release: LabCorp is first US laboratory to offer molecular testing with new fully automated cobas 8800 system from Roche

Courtesy of PR Newswire Complimentary Monitoring Press Release: LabCorp is first US laboratory to offer molecular testing with new fully automated cobas 8800 system from Roche Dow Jones & Company, Inc. -- October 24, 2016 LabCorp is first US laboratory to offer molecular testing with new fully

LabCorp Subsidiary Sequenom, Inc. Announces Expiration of and Final Tender Results for Tender Offers for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018

BURLINGTON, N.C. & SAN DIEGO --(BUSINESS WIRE)--Oct. 18, 2016-- Sequenom, Inc. (“Sequenom”), a wholly-owned subsidiary of Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH), announced the final results, as of 5:00 p.m. , New York City time, on Monday, October 17, 2016 (the

Covance Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award Three Years Running

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 12, 2016-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that Covance Drug Development (“Covance”) has been awarded the 2016 Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award.

Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Oct. 3, 2016-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.

LabCorp Subsidiary Sequenom, Inc. Announces Early Tender Results for Tender Offers and Successful Completion of Consent Solicitations for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018

BURLINGTON, N.C. & SAN DIEGO --(BUSINESS WIRE)--Sep. 30, 2016-- Sequenom, Inc. (“Sequenom”), a wholly-owned subsidiary of Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH), announced the results, as of 5:00 p.m. , New York City time, on September 29, 2016 (the “Early Tender

LabCorp Names Veteran Biopharma Executive John Ratliff CEO of Covance Drug Development

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 20, 2016-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE:LH), the world’s leading healthcare diagnostics company, today announced that veteran biopharmaceutical executive John Ratliff will succeed Deborah Keller as CEO of Covance Drug

LabCorp Subsidiary Sequenom Inc. Announces Tender Offers and Consent Solicitations for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018

BURLINGTON, N.C. & SAN DIEGO --(BUSINESS WIRE)--Sep. 16, 2016-- Sequenom, Inc. , a wholly-owned subsidiary of Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH), announced the commencement of cash tender offers (the “Tender Offers”) for any and all of the outstanding 5%